Silverarc Capital Management, LLC Poly Pid Ltd. Transaction History

Silverarc Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$4.35 - $5.76 $246,223 - $326,033	-56,603 Reduced 25.94%	161,572 $750,000
Q1 2022 May 13, 2022	BUY	$3.92 - $6.25 $10,015 - $15,968	2,555 Added 1.18%	218,175 $1.19 Million
Q4 2021 Feb 14, 2022	BUY	$5.52 - $8.42 $178,792 - $272,723	32,390 Added 17.68%	215,620 $1.24 Million
Q3 2021 Nov 15, 2021	BUY	$7.05 - $9.48 $202,081 - $271,734	28,664 Added 18.54%	183,230 $1.43 Million
Q2 2021 Aug 16, 2021	BUY	$8.4 - $9.99 $39,816 - $47,352	4,740 Added 3.16%	154,566 $1.4 Million
Q1 2021 May 18, 2021	BUY	$8.92 - $15.5 $1.34 Million - $2.32 Million	149,826 New	149,826 $1.37 Million

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $59.2M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.